CATCH ME: Improving the lives of patients with Atrial Fibrillation

Catch me

CATCH ME: Improving the lives of patients with Atrial Fibrillation

Pera International is delighted to announce its support to the CATCH ME Research and Innovation Action European Project.

The European project CATCH ME brings together 6 academic expert institutes, 3 healthcare organisations and 2 leading professional organisations with the intention to improve the care of patients with Atrial Fibrillation (AF). The projects long title is CATCH ME – Characterising Atrial Fibrillation by Translating its Causes into Health Modifiers in the Elderly. The EC’s new Horizon 2020 EU research and innovation programme supports the consortium with a 5 million euro grant over 4 years.

On the 21 May 2015 the CATCH ME EU research consortium first formally met and the project was launched at the Brussels office of the European Society of Cardiology (ESC).

Catch ME group

2% of the European population and 12-15% of Europe’s octogenarians suffer from AF, a cardiac disease putting them at risk of stroke, cognitive decline, heart failure, and premature death. CATCH ME aims to improve the prevention and treatment of AF and its complications. The goal is to develop and validate better disease management strategies based on the improved understanding of the main health modifiers such as, genes, drugs, and behaviour leading to AF in the European population. More specifically, the CATCH ME project will: 

  1. Identify the major health modifiers causing AF in the elderly in Europe
  2. Develop clinical tools that will personalise the prevention and management of AF patients, and 
  3. Guide and strengthen future strategies to prevent, diagnose, and treat AF in Europe

Beyond evidence generation and therapy recommendations, CATCH ME will combine its research excellence with the knowledge transfer and communication competence of the ESC and the AF NETwork (AFNET) for the result dissemination. The consortium is working closely together with a global leader in in-vitro diagnostics tests (Roche Professional Diagnostics) who will support the development of existing and novel intellectual property in the consortium into marketable tests. Thus, CATCH ME will generate tangible and sustained improvements in the prevention and management of AF patients in Europe.

CATCH ME will propose the novel AF classification to researchers, health care professionals and patients throughout Europe. This will be realised by solid scientific underpinning of the clinical tools, educational programmes and by world-wide provision of CATCH ME apps that can be used on any smart phone.

The benefits for Pera International members are that they:

  • Will be represented at major conferences and will have the opportunity to be involved in the CATCH ME project dissemination activities
  • Will have access to the smart phone pilot app and the associated platform for patients
  • Will have marketing and publicity opportunities via the project that Pera Technology Limited will be managing

The consortium is being led by Professor Paulus Kirchhof from the University of Birmingham (UK) and consists of the following 9 partners:

  • University of Birmingham (UK)
  • Universidad de Barcelona (Spain)
  • Maastricht University (Netherlands)
  • Ludwig-Maximilians University Munich (Germany)
  • University of Oxford (UK)
  • Université Pierre Marie Curie (France)
  • Atrial Fibrillation Network (Germany)
  • European Society of Cardiology (France)
  • UK Health & Environment Research Institute (UK-HERI), a subsidiary of Pera Technology Limited

The following third parties are also actively involved:

  • Roche Professional Diagnostics (Switzerland)
  • Parkrun (UK)

For further general information please go to